– USA, CA – Natus Medical Incorporated (NASDAQ:BABY) today announced the appointment of Barbara R. Paul, M.D. to its board of directors.
“We are pleased to have Dr. Paul join the Natus Board of Directors,” said Robert Gunst, chairman of Natus’ board of directors. “Dr. Paul’s significant medical and regulatory experience will complement the expertise of our current Board members.”
Dr. Paul currently sits on the board of Quorum Health Corporation, an operator and manager of 38 general acute care hospitals and outpatient services. She served as Senior Vice President & Chief Medical Officer at Community Health Systems from July 2007 to January 2015. Prior to CHS, Dr. Paul was Senior Vice President & Chief Medical Officer for Beverly Enterprises, Inc. Dr. Paul’s career is grounded by twelve years as a board-certified internist and full-time primary care physician. She also worked at the federal Medicare program for appointees of Presidents Clinton and Bush. She was Director of the Department of Quality Measurement & Health Assessment. Dr. Paul has a bachelor of science from the University of Wisconsin – Madison and earned her medical degree from Stanford University School of Medicine.
“We are excited to have Dr. Paul join the Natus board of directors,” said Jim Hawkins, President and Chief Executive Officer of the Company. “Dr. Paul’s background in patient care and at CMS will bring a unique perspective to our board and be invaluable as we grow.”
About Natus Medical Incorporated
Natus is a leading provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
